Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Nitazoxanide plus PEG-IFN/RBV beneficial in HCV genotype 1

April 26, 2010

PREEMPT trials show benefit of Botox in chronic migraine

April 26, 2010

Tanezumab shows benefit in patients with interstitial cystitis

April 23, 2010

Tacrolimus improves symptoms of bladder pain syndrome/interstitial cystitis

April 23, 2010

Nerviano Medical Sciences discovers new B-raf inhibitors for cancer therapy

April 23, 2010

BAL-30072 active against beta-lactamase-producing enterobacteria in vivo

April 23, 2010

Cempra presents preclinical and clinical phase I data on CEM-101 antibiotic

April 23, 2010

Clinical data support safety and efficacy of BI-207127 plus PEG-IFN/RBV in HCV genotype 1

April 23, 2010

Pfizer describes new oxazolidinone antibacterial

April 22, 2010

Cheminpharma presents preclinical data on new MEK 1 inhibitor

April 22, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...